0106 GMT - IHH Healthcare could see a decent growth trajectory into 2026, driven mainly by Malaysia and India markets, TA Securities analyst Tan Kong Jin says in a note. In Malaysia, revenue is forecast to grow 12.3%, supported by higher day care volumes, medical tourism and bed expansion, while margins are set to improve on cost discipline, he says. India operations could recover as integration between Fortis and Gleneagles units improves efficiency and margins, he reckons. Singapore market should stabilize by 2H, supported by the ramp-up of ambulatory care centers, medical tourism growth, and the expansion of Mount Elizabeth hospital, he adds. TA Securities maintains a buy rating on IHH and keeps the target price at 10.30 ringgit. Shares are unchanged at 8.85 ringgit.(yingxian.wong@wsj.com)
(END) Dow Jones Newswires
April 23, 2026 21:06 ET (01:06 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments